FDA.reportPublic FDA data

GOPRELTO 4 % Nasal Solution

RxCUI
1995293
RxNorm name
GOPRELTO 4 % Nasal Solution
Display name
GOPRELTO 4 % Nasal Solution
Full name
GOPRELTO 4 % Nasal Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
GopreltoCOCAINE HYDROCHLORIDELXO US Inc.0f897764-fe30-090a-e063-6294a90af1062024-11-06Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1995293

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0f897764-fe30-090a-e063-6294a90af106GOPRELTO 4 % Nasal Solution [PSN] · cocaine hydrochloride 40 MG/ML Nasal Solution [Goprelto] [SBD] · Goprelto 4 % Nasal Solution [SY] · Goprelto 40 MG/ML Nasal Solution [SY]41These highlights do not include all the information needed to use GOPRELTO safely and effectively. See full prescribing information for GOPRELTO. GOPRELTO (cocaine hydrochloride) nasal solution, for intranasal use, CII Initial U.S. Approval: 201720241106